Ronen Twito

Ronen Twito is executive chairman and chief executive officer of NewcelX, the company formed when Kadimastem merged with NLS Pharmaceutics. He joined Kadimastem as executive chairman in 2020 and became its chief executive four years later, before carrying both roles into the merged company. A certified public accountant in Israel, he has spent more than two decades leading biotechnology and technology companies listed on Nasdaq and the Tel Aviv Stock Exchange.

Affiliation

Executive Chairman and Chief Executive Officer, NewcelX

Location

Nes Ziona, Israel